Results 171 to 180 of about 24,787 (310)

Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic dermatitis: A population-based cohort study [PDF]

Serena Yun‐Chen Tsai, Wanda Phipatanakul, Elena B. Hawryluk, Michiko K. Oyoshi, Lynda C. Schneider, Kevin Sheng‐Kai   +5 more
openalex   +1 more source

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report [PDF]

, 2020
Madeeha Mian, Rachel Dunlap, Eric L. Simpson   +2 more
openalex   +1 more source

Are Phenotypic Baseline Characteristics Related to Abolition of AHR After Benralizumab and Dupilumab?

Clinical &Experimental Allergy, EarlyView.
Philipp Suter, Robert Greig, Rory Chan, Brian J. Lipworth   +3 more
wiley   +1 more source

Mucous Membrane Pemphigoid After Anti‐PD‐1 Therapy: Risk‐Stratified Management and Treatment Outcomes

International Journal of Dermatology, EarlyView.
ABSTRACT Mucous membrane pemphigoid (MMP) following anti‐programmed cell death‐1 (PD‐1) therapy is rare but increasingly reported. Management of high‐ and low‐risk MMP in this setting and the potential oncologic trade‐offs remain poorly defined. We performed a narrative synthesis of all published cases of anti‐PD‐1‐associated MMP, following MEDLINE ...
Serena Dienes, Negar Esfandiari, Steven Daveluy   +2 more
wiley   +1 more source

Eosinophilic Organ Complications Associated with Dupilumab Therapy - Narrative Review and Current Evidence. [PDF]

J Asthma Allergy
Suter P, Buetler VA, Graf N, Pavlov N.
europepmc   +1 more source

Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials

Amy S. Paller, Elaine C. Siegfried, Michael J. Cork, Kenji Kabashima, Peter D. Arkwright, Edyta Gębska, Zhen Chen, Joseph Zahn, Ana B. Rossi   +8 more
openalex   +2 more sources

Detection and Management of Eosinophilia in Asthmatic Adults and Children Receiving Dupilumab Treatment: A Focused Review. [PDF]

J Inflamm Res
Caminati M, Cefaloni F, Tenero L, De Corso E, Micheletto C, Piacentini G.   +5 more
europepmc   +1 more source

No meaningful body weight gain in adults with moderate-to-severe atopic dermatitis treated with dupilumab for 1 year

Mark Lebwohl, Stephan Weidinger, April Armstrong, Zhen Chen, Mike Bastian, Tien V Nguyen, João Costa   +6 more
openalex   +1 more source

Rapid and long‐lasting remission of refractory Hailey‐Hailey disease by IL‐13 inhibition with tralokinumab

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Oliver Brandt, Stephanie M. Huber, Simon M. Mueller   +2 more
wiley   +1 more source

scRNA‐Seq reveals anti‐lymphoma immune responses in mogamulizumab‐associated skin eruptions

Journal of the European Academy of Dermatology and Venereology, EarlyView.
CCR4 was expressed in malignant clones and regulatory T cells in untreated CTCL, that were decreased in MAR. Malignant clones in MAR showed a silenced phenotype with decreases in central memory markers SELL and CCR7, and GTP‐binding member GIMAP7 and upregulation of MMP2 inhibitor TIMP2 and tumour suppressor gene RUNX3.
Shannon Meledathu, Agata Kurowski, Malini P. Naidu, Jonas Adalsteinsson, Shane A. Meehan, Natalia Alkon, Lauren R. Port, Sumanth Chennareddy, Emry R. Cohenour, Grace Christensen, Jonah Shulman, Nicholas Gulati, Constanze Jonak, Patrick M. Brunner   +13 more
wiley   +1 more source